Currency Economy

Waiving patents alone won’t solve COVID-19 vaccine access: developers

Coronavirus (Mar 08, 2021 01:15PM ET) Waiving patents alone won't solve COVID-19 vaccine access: developers

© Reuters. FILE PHOTO: A woman holds a small bottle labelled with a “Coronavirus COVID-19 Vaccine” in this illustration

GENEVA (Reuters) – Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a meeting on the topic at the World Trade Organization this week.

“I don’t think just making IP fully available goes anywhere close to solving the problem…,” said the University of Oxford professor Sarah Gilbert at a World Health Organization virtual press conference.

BioNTech’s Chief Medical Officer Dr Özlem Türeci said at the same briefing: “Patents are one thing, but there are so many other things we have to ensure.”Waiving patents alone won’t solve COVID-19 vaccine access: developers Add a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s